mRNA vaccine development for cholangiocarcinoma: a precise pipeline

被引：7
|
作者：
Tang, Tian-Yu [1 ,2 ,3 ,4 ,5 ]
Huang, Xing [1 ,2 ,3 ,4 ,5 ]
Zhang, Gang [1 ,2 ,3 ,4 ,5 ]
Lu, Ming-Hao [1 ,2 ,3 ,4 ,5 ]
Liang, Ting-Bo [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Pancreat Dis, Sch Med, Hangzhou 310009, Peoples R China
[3] Zhejiang Clin Res Ctr Hepatobiliary & Pancreat Di, Hangzhou 310003, Zhejiang, Peoples R China
[4] Innovat Ctr Study Pancreat Dis Zhejiang Prov, Hangzhou 310009, Peoples R China
[5] Zhejiang Univ, Canc Ctr, Hangzhou 310058, Peoples R China
来源：
MILITARY MEDICAL RESEARCH | 2022年 / 9卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Cholangiocarcinoma (CHOL); mRNA vaccine; Tumor antigen; Immune subtype; Immune microenvironment; METASTATIC CHOLANGIOCARCINOMA; IMMUNE-RESPONSES; STRANDED-RNA; WEB SERVER; CANCER; CHEMOTHERAPY; RECOGNITION; MULTICENTER; GEMCITABINE; PEPTIDE;
D O I：
10.1186/s40779-022-00399-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cholangiocarcinoma (CHOL) is one of the most aggressive tumors worldwide and cannot be effectively treated by conventional and novel treatments, including immune checkpoint blockade therapy. The mRNA vaccine-based immunotherapeutic strategy has attracted much attention for various diseases, however, its application in CHOL is limited due to the thoughtlessness in the integration of vaccine design and patient selection. A recent study established an integrated path for identifying potent CHOL antigens for mRNA vaccine development and a precise stratification for identifying CHOL patients who can benefit from the mRNA vaccines. In spite of a promising prospect, further investigations should identify immunogenic antigens and onco-immunological characteristics of CHOL to guide the clinical application of CHOL mRNA vaccines in the future.
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Rational development of multicomponent mRNA vaccine candidates against mpox
    Zhang, Rong-Rong
    Wang, Zheng-Jian
    Zhu, Yi-Long
    Tang, Wei
    Zhou, Chao
    Zhao, Suo-Qun
    Wu, Mei
    Ming, Tao
    Deng, Yong-Qiang
    Chen, Qi
    Jin, Ning-Yi
    Ye, Qing
    Li, Xiao
    Qin, Cheng-Feng
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [32] Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
    Sudha Chivukula
    Timothy Plitnik
    Timothy Tibbitts
    Shrirang Karve
    Anusha Dias
    Donghui Zhang
    Rebecca Goldman
    Hardip Gopani
    Asad Khanmohammed
    Ashish Sarode
    Dustin Cooper
    Heesik Yoon
    Younghoon Kim
    Yanhua Yan
    Sophia T. Mundle
    Rachel Groppo
    Adrien Beauvais
    Jinrong Zhang
    Natalie G. Anosova
    Charles Lai
    Lu Li
    Gregory Ulinski
    Peter Piepenhagen
    Joshua DiNapoli
    Kirill V. Kalnin
    Victoria Landolfi
    Ron Swearingen
    Tong-Ming Fu
    Frank DeRosa
    Danilo Casimiro
    npj Vaccines, 6
  • [33] mRNA vaccine development and applications: A special focus on tumors (Review)
    Chen, Bangjie
    Yang, Yipin
    Wang, Xinyi
    Yang, Wenzhi
    Lu, You
    Wang, Daoyue
    Zhuo, Enba
    Tang, Yanchao
    Su, Junhong
    Tang, Guozheng
    Shao, Song
    Gu, Kangsheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2024, 65 (02)
  • [34] mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
    Maruggi, Giulietta
    Zhang, Cuiling
    Li, Junwei
    Ulmer, Jeffrey B.
    Yu, Dong
    MOLECULAR THERAPY, 2019, 27 (04) : 757 - 772
  • [35] Perspectives and Prospects on mRNA Vaccine Development for COVID-19
    Jin, Lihui
    Han, Zhenyuan
    Zhao, Pengjun
    Sun, Kun
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (23) : 3991 - 3996
  • [36] Nanoparticle-based delivery platforms for mRNA vaccine development
    Okay, Sezer
    Ozcan, Oznur Ozge
    Karahan, Mesut
    AIMS BIOPHYSICS, 2020, 7 (04): : 323 - 338
  • [37] Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
    Chivukula, Sudha
    Plitnik, Timothy
    Tibbitts, Timothy
    Karve, Shrirang
    Dias, Anusha
    Zhang, Donghui
    Goldman, Rebecca
    Gopani, Hardip
    Khanmohammed, Asad
    Sarode, Ashish
    Cooper, Dustin
    Yoon, Heesik
    Kim, Younghoon
    Yan, Yanhua
    Mundle, Sophia T.
    Groppo, Rachel
    Beauvais, Adrien
    Zhang, Jinrong
    Anosova, Natalie G.
    Lai, Charles
    Li, Lu
    Ulinski, Gregory
    Piepenhagen, Peter
    DiNapoli, Joshua
    Kalnin, Kirill, V
    Landolfi, Victoria
    Swearingen, Ron
    Fu, Tong-Ming
    DeRosa, Frank
    Casimiro, Danilo
    NPJ VACCINES, 2021, 6 (01)
  • [38] Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma
    Wang, Si-Qin
    Chai, Chu-Xing
    Wang, Bi-Rong
    Zhu, Feng
    Shang, Dan
    Li, Min
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (01) : 362 - 365
  • [39] Liquid biopsy: Precise diagnosis and therapy for cholangiocarcinoma
    Si-Qin Wang
    Chu-Xing Chai
    Bi-Rong Wang
    Feng Zhu
    Dan Shang
    Min Li
    World Journal of Gastrointestinal Oncology, 2022, (01) : 362 - 365
  • [40] More precise targeting of drugs in pipeline
    Tonks, A
    BRITISH MEDICAL JOURNAL, 1998, 316 (7129): : 412 - 412
12345